{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T21:28:40Z","timestamp":1779312520174,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.vaccine.2012.04.047","type":"journal-article","created":{"date-parts":[[2012,4,26]],"date-time":"2012-04-26T05:01:46Z","timestamp":1335416506000},"page":"4225-4232","source":"Crossref","is-referenced-by-count":16,"title":["Physicochemically stable cholera toxin B subunit pentamer created by peripheral molecular constraints imposed by de novo-introduced intersubunit disulfide crosslinks"],"prefix":"10.1016","volume":"30","author":[{"given":"Takeshi","family":"Miyata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Oshiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Harakuni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toki","family":"Taira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goro","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"December (4)","key":"10.1016\/j.vaccine.2012.04.047_bib0005","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/MMBR.56.4.622-647.1992","article-title":"Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin","volume":"56","author":"Spangler","year":"1992","journal-title":"Microbiology Reviews"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2012.04.047_bib0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0959-440X(95)80071-9","article-title":"AB5 toxins","volume":"5","author":"Merritt","year":"1995","journal-title":"Current Opinion in Structural Biology"},{"issue":"March (4)","key":"10.1016\/j.vaccine.2012.04.047_bib0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.toxicon.2004.12.014","article-title":"Cholera and Shiga toxin B-subunits: thermodynamic and structural considerations for function and biomedical applications","volume":"45","author":"Pina","year":"2005","journal-title":"Toxicon"},{"issue":"10","key":"10.1016\/j.vaccine.2012.04.047_bib0020","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/j.biocel.2007.07.005","article-title":"Vibrio cholerae: cholera toxin","volume":"39","author":"Vanden Broeck","year":"2007","journal-title":"The International Journal of Biochemistry and Cell Biology"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.04.047_bib0025","first-page":"153","article-title":"Cholera toxin\u2014a foe & a friend","volume":"133","author":"Sanchez","year":"2011","journal-title":"The Indian Journal of Medical Research"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.04.047_bib0030","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/eji.1830220915","article-title":"The adjuvant effect of Vibrio cholerae and Escherichia coli heat-labile enterotoxins is linked to their ADP-ribosyltransferase activity","volume":"22","author":"Lycke","year":"1992","journal-title":"European Journal of Immunology"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2012.04.047_bib0035","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2004.11.009","article-title":"Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA","volume":"97","author":"Holmgren","year":"2005","journal-title":"Immunology Letters"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.04.047_bib0040","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1128\/IAI.00640-09","article-title":"Malaria ookinete surface protein-based vaccination via the intranasal route completely blocks parasite transmission in both passive and active vaccination regimens in a rodent model of malaria infection","volume":"77","author":"Arakawa","year":"2009","journal-title":"Infection and Immunity"},{"issue":"November (9)","key":"10.1016\/j.vaccine.2012.04.047_bib0045","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"Journal of Immunology"},{"issue":"July (8499)","key":"10.1016\/j.vaccine.2012.04.047_bib0050","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(86)91944-6","article-title":"Field trial of oral cholera vaccines in Bangladesh","volume":"2","author":"Clemens","year":"1986","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vaccine.2012.04.047_bib0055","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/0264-410X(93)90380-G","article-title":"Intestinal antibody response after oral immunization with a prototype cholera B subunit-colonization factor antigen enterotoxigenic Escherichia coli vaccine","volume":"11","author":"Ahren","year":"1993","journal-title":"Vaccine"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2012.04.047_bib0060","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.4049\/jimmunol.163.2.1045","article-title":"Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice","volume":"163","author":"Sun","year":"1999","journal-title":"Journal of Immunology"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.04.047_bib0065","doi-asserted-by":"crossref","first-page":"5654","DOI":"10.1128\/IAI.73.9.5654-5665.2005","article-title":"Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induce systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems","volume":"73","author":"Harakuni","year":"2005","journal-title":"Infection and Immunity"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.04.047_bib0070","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1128\/IAI.00306-10","article-title":"Plasmodium vivax ookinete surface protein Pvs25 linked to cholera toxin B subunit induces potent transmission-blocking immunity by intranasal as well as subcutaneous immunization","volume":"78","author":"Miyata","year":"2010","journal-title":"Infection and Immunity"},{"issue":"January (5)","key":"10.1016\/j.vaccine.2012.04.047_bib0075","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.vaccine.2011.11.059","article-title":"Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice","volume":"30","author":"Miyata","year":"2012","journal-title":"Vaccine"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2012.04.047_bib0080","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1006\/jmbi.1995.0456","article-title":"The three-dimensional crystal structure of cholera toxin","volume":"251","author":"Zhang","year":"1995","journal-title":"Journal of Molecular Biology"},{"issue":"May (6325)","key":"10.1016\/j.vaccine.2012.04.047_bib0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/351371a0","article-title":"Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli","volume":"351","author":"Sixma","year":"1991","journal-title":"Nature"},{"issue":"April (3)","key":"10.1016\/j.vaccine.2012.04.047_bib0090","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1006\/jmbi.1993.1209","article-title":"Refined structure of Escherichia coli heat-labile enterotoxin, a close relative of cholera toxin","volume":"230","author":"Sixma","year":"1993","journal-title":"Journal of Molecular Biology"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.04.047_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0969-2126(00)00007-1","article-title":"The crystal structure of pertussis toxin","volume":"2","author":"Stein","year":"1994","journal-title":"Structure"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2012.04.047_bib0100","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nsb0194-59","article-title":"Crystal structure of the holotoxin from Shigella dysenteriae at 2.5 A resolution","volume":"1","author":"Fraser","year":"1994","journal-title":"Nature Structural Biology"},{"issue":"February (6362)","key":"10.1016\/j.vaccine.2012.04.047_bib0105","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/355748a0","article-title":"Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli","volume":"355","author":"Stein","year":"1992","journal-title":"Nature"},{"issue":"June (26)","key":"10.1016\/j.vaccine.2012.04.047_bib0110","doi-asserted-by":"crossref","first-page":"27511","DOI":"10.1074\/jbc.M401939200","article-title":"Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O157:H7","volume":"279","author":"Fraser","year":"2004","journal-title":"The Journal of Biological Chemistry"},{"issue":"August (4)","key":"10.1016\/j.vaccine.2012.04.047_bib0115","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1006\/jmbi.1995.0455","article-title":"The 2.4 A crystal structure of cholera toxin B subunit pentamer: choleragenoid","volume":"251","author":"Zhang","year":"1995","journal-title":"Journal of Molecular Biology"},{"issue":"August (1)","key":"10.1016\/j.vaccine.2012.04.047_bib0120","first-page":"83","article-title":"Effects of ganglioside GM1 on the thermotropic behavior of cholera toxin B subunit","volume":"63","author":"Dalziel","year":"1984","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"March (6)","key":"10.1016\/j.vaccine.2012.04.047_bib0125","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1021\/bi00406a035","article-title":"Thermal stability and intersubunit interactions of cholera toxin in solution and in association with its cell-surface receptor ganglioside GM1","volume":"27","author":"Goins","year":"1988","journal-title":"Biochemistry (Moscow)"},{"issue":"May (20)","key":"10.1016\/j.vaccine.2012.04.047_bib0130","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1021\/bi00234a031","article-title":"Thermodynamic identification of stable folding intermediates in the B-subunit of cholera toxin","volume":"30","author":"Bhakuni","year":"1991","journal-title":"Biochemistry (Moscow)"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2012.04.047_bib0135","doi-asserted-by":"crossref","first-page":"16697","DOI":"10.1074\/jbc.M110561200","article-title":"A kinetic model of intermediate formation during assembly of cholera toxin B-subunit pentamers","volume":"277","author":"Lesieur","year":"2002","journal-title":"The Journal of Biological Chemistry"},{"issue":"September (2)","key":"10.1016\/j.vaccine.2012.04.047_bib0140","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0022-2836(81)90515-5","article-title":"Disulphide bridges in globular proteins","volume":"151","author":"Thornton","year":"1981","journal-title":"Journal of Molecular Biology"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2012.04.047_bib0145","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jps.10296","article-title":"Thermal stability of vaccines","volume":"92","author":"Brandau","year":"2003","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"September (41)","key":"10.1016\/j.vaccine.2012.04.047_bib0150","doi-asserted-by":"crossref","first-page":"7122","DOI":"10.1016\/j.vaccine.2011.05.070","article-title":"Vaccine stabilization: research, commercialization, and potential impact","volume":"29","author":"Kristensen","year":"2011","journal-title":"Vaccine"},{"issue":"December (24)","key":"10.1016\/j.vaccine.2012.04.047_bib0155","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1128\/JVI.01553-08","article-title":"Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines","volume":"82","author":"Mateo","year":"2008","journal-title":"Journal of Virology"},{"issue":"February (5)","key":"10.1016\/j.vaccine.2012.04.047_bib0160","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.vaccine.2009.11.024","article-title":"Heat-stable measles vaccine produced by spray drying","volume":"28","author":"Ohtake","year":"2010","journal-title":"Vaccine"},{"issue":"July (31)","key":"10.1016\/j.vaccine.2012.04.047_bib0165","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1016\/j.vaccine.2010.04.112","article-title":"Thermostable formulations of a hepatitis B vaccine and a meningitis A polysaccharide conjugate vaccine produced by a spray drying method","volume":"28","author":"Chen","year":"2010","journal-title":"Vaccine"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2012.04.047_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MMBR.65.1.1-43.2001","article-title":"Hyperthermophilic enzymes: sources, uses, and molecular mechanisms for thermostability","volume":"65","author":"Vieille","year":"2001","journal-title":"Microbiology and Molecular Biology Reviews: MMBR"},{"issue":"September (18)","key":"10.1016\/j.vaccine.2012.04.047_bib0175","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1111\/j.1742-4658.2006.05421.x","article-title":"Protein disulfides and protein disulfide oxidoreductases in hyperthermophiles","volume":"273","author":"Ladenstein","year":"2006","journal-title":"The FEBS Journal"},{"issue":"July (15)","key":"10.1016\/j.vaccine.2012.04.047_bib0180","doi-asserted-by":"crossref","first-page":"9679","DOI":"10.1073\/pnas.142310499","article-title":"Genomic evidence that the intracellular proteins of archaeal microbes contain disulfide bonds","volume":"99","author":"Mallick","year":"2002","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2012.04.047_bib0185","doi-asserted-by":"crossref","first-page":"e309","DOI":"10.1371\/journal.pbio.0030309","article-title":"The genomics of disulfide bonding and protein stabilization in thermophiles","volume":"3","author":"Beeby","year":"2005","journal-title":"PLoS Biology"},{"issue":"August (2)","key":"10.1016\/j.vaccine.2012.04.047_bib0190","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/jmbi.2000.3970","article-title":"The crystal structure of adenylosuccinate lyase from Pyrobaculum aerophilum reveals an intracellular protein with three disulfide bonds","volume":"301","author":"Toth","year":"2000","journal-title":"Journal of Molecular Biology"},{"issue":"November (6247)","key":"10.1016\/j.vaccine.2012.04.047_bib0195","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/342291a0","article-title":"Substantial increase of protein stability by multiple disulphide bonds","volume":"342","author":"Matsumura","year":"1989","journal-title":"Nature"},{"issue":"December (4)","key":"10.1016\/j.vaccine.2012.04.047_bib0200","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jmb.2003.10.006","article-title":"Stabilization of a tetrameric malate dehydrogenase by introduction of a disulfide bridge at the dimer-dimer interface","volume":"334","author":"Bjork","year":"2003","journal-title":"Journal of Molecular Biology"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2012.04.047_bib0205","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1002\/pro.5560061220","article-title":"Crystal structure of a non-toxic mutant of heat-labile enterotoxin, which is a potent mucosal adjuvant","volume":"6","author":"van den Akker","year":"1997","journal-title":"Protein Science"},{"issue":"August (5)","key":"10.1016\/j.vaccine.2012.04.047_bib0210","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jmb.2004.06.079","article-title":"Large improvement in the thermal stability of a tetrameric malate dehydrogenase by single point mutations at the dimer\u2013dimer interface","volume":"341","author":"Bjork","year":"2004","journal-title":"Journal of Molecular Biology"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2012.04.047_bib0215","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1110\/ps.04897904","article-title":"Improved stability of a protein vaccine through elimination of a partially unfolded state","volume":"13","author":"McHugh","year":"2004","journal-title":"Protein Science: A Publication of the Protein Society"},{"issue":"October (23)","key":"10.1016\/j.vaccine.2012.04.047_bib0220","doi-asserted-by":"crossref","first-page":"12528","DOI":"10.1016\/S0021-9258(17)38903-2","article-title":"Chemical and immunochemical studies on the receptor binding domain of cholera toxin B subunit","volume":"260","author":"Ludwig","year":"1985","journal-title":"The Journal of biological chemistry"},{"issue":"2","key":"10.1016\/j.vaccine.2012.04.047_bib0225","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/jss.400100204","article-title":"Structure, function, and antigenicity of cholera toxin","volume":"10","author":"Markel","year":"1979","journal-title":"Journal of Supramolecular Structure"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2012.04.047_bib0230","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/bj1890507","article-title":"Degradation of protein disulphide bonds in dilute alkali","volume":"189","author":"Florence","year":"1980","journal-title":"The Biochemical Journal"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1200583X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X1200583X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T22:51:53Z","timestamp":1713912713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X1200583X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":46,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S0264410X1200583X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2012.04.047","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}